Bonesupport Holding
ISIN: SE0009858152 | Ticker: BONEX | LEI: 549300COLY053IGTLD63
Country: Sweden
BONESUPPORT AB is a Scandinavian orthobiologics company that develops and markets CERAMENT®, an innovative range of radiopaque injectable osteoconductive and drug-eluting bioceramic products that have a proven ability to heal defects by remodeling to host bone in six to twelve months.
Our products are effective in treating patients with fractures and bone voids caused by trauma, infection, disease or related surgery.
2000
Served areaEurope
HeadquartersScheelevägen 19, 22370 Lund – Sweden
| Line item in (sek) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 465,218,000.00 | 343,919,000.00 | 371,818,000.00 |
| Noncurrent Assets | N/A | 23,843,000.00 | 35,443,000.00 | 33,010,000.00 |
| Property Plant And Equipment | N/A | 3,163,000.00 | 4,574,000.00 | 5,764,000.00 |
| Intangible Assets Other Than Goodwill | N/A | 8,840,000.00 | 8,365,000.00 | 8,384,000.00 |
| Copyrights Patents And Other Industrial Property Rights Service And Operating Rights | N/A | 2,725,000.00 | 2,397,000.00 | 2,075,000.00 |
| Current Assets | N/A | 441,375,000.00 | 308,476,000.00 | 338,808,000.00 |
| Inventories | N/A | 45,555,000.00 | 51,762,000.00 | 56,310,000.00 |
| Finished Goods | N/A | 14,604,000.00 | 17,528,000.00 | 17,867,000.00 |
| Trade And Other Current Receivables | N/A | 42,083,000.00 | 50,250,000.00 | 81,217,000.00 |
| Current Trade Receivables | N/A | 32,108,000.00 | 38,413,000.00 | 62,623,000.00 |
| Current Prepaid Expenses | N/A | 3,359,000.00 | 3,219,000.00 | 4,926,000.00 |
| Other Current Receivables | N/A | 5,317,000.00 | 6,126,000.00 | 7,963,000.00 |
| Cash and cash equivalents | 92,065,000.00 | 353,737,000.00 | 206,464,000.00 | 201,281,000.00 |
| Equity And Liabilities | N/A | 465,218,000.00 | 343,919,000.00 | 371,818,000.00 |
| Equity | 124,309,000.00 | 398,899,000.00 | 265,704,000.00 | 268,928,000.00 |
| Retained Earnings | N/A | -1,203,823,000.00 | -1,344,494,000.00 | -1,344,676,000.00 |
| Share Premium | N/A | 1,557,639,000.00 | 1,563,670,000.00 | 1,563,836,000.00 |
| Liabilities | N/A | 66,319,000.00 | 78,215,000.00 | 102,890,000.00 |
| Noncurrent Liabilities | N/A | 5,951,000.00 | 16,515,000.00 | 12,694,000.00 |
| Noncurrent Provisions | N/A | 329,000.00 | 363,000.00 | 344,000.00 |
| Current Liabilities | N/A | 60,368,000.00 | 61,700,000.00 | 90,196,000.00 |
| Trade And Other Current Payables To Trade Suppliers | N/A | 12,680,000.00 | 18,719,000.00 | 23,571,000.00 |
| Accruals Classified As Current | N/A | 30,871,000.00 | 30,183,000.00 | 54,083,000.00 |
| Current Tax Liabilities Current | N/A | 4,985,000.00 | 1,903,000.00 | 1,097,000.00 |
| Other Current Liabilities | N/A | 6,974,000.00 | 5,625,000.00 | 6,344,000.00 |
| Line item in (sek) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue From Sale Of Goods | 180,860,000.00 | 212,885,000.00 | 328,818,000.00 |
| Revenue From Interest | N/A | 0.00 | 811,000.00 |
| Other Income | 12,188,000.00 | 11,308,000.00 | 43,206,000.00 |
| Profit Loss From Operating Activities | -98,561,000.00 | -80,669,000.00 | -64,535,000.00 |
| Finance Income | 5,000.00 | 0.00 | N/A |
| Finance Costs | 445,000.00 | 1,168,000.00 | N/A |
| Profit Loss Before Tax | -99,001,000.00 | -81,837,000.00 | -64,694,000.00 |
| Income Tax Expense Continuing Operations | 2,411,000.00 | 3,694,000.00 | 3,473,000.00 |
| Profit (loss) | -101,412,000.00 | -85,531,000.00 | -68,167,000.00 |
| Profit Loss Attributable To Owners Of Parent | -101,412,000.00 | -85,531,000.00 | -68,167,000.00 |
| Line item in (sek) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Profit (loss) | N/A | -101,412,000.00 | -85,531,000.00 | -68,167,000.00 |
| Adjustments For Decrease Increase In Inventories | N/A | -13,202,000.00 | -117,000.00 | 7,077,000.00 |
| Interest Paid Classified As Operating Activities | N/A | 6,000.00 | 1,168,000.00 | 716,000.00 |
| Interest Received Classified As Operating Activities | N/A | 5,000.00 | 0.00 | 811,000.00 |
| Cash Flows From Used In Operating Activities | N/A | -100,275,000.00 | -83,421,000.00 | -46,985,000.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 346,000.00 | 2,608,000.00 | 1,958,000.00 |
| Purchase Of Intangible Assets Classified As Investing Activities | N/A | 2,312,000.00 | 808,000.00 | 1,321,000.00 |
| Cash Flows From Used In Investing Activities | N/A | -2,658,000.00 | -3,416,000.00 | -3,279,000.00 |
| Proceeds From Issuing Shares | N/A | 378,000,000.00 | 0.00 | N/A |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 7,768,000.00 | 5,509,000.00 | 8,132,000.00 |
| Cash Flows From Used In Financing Activities | N/A | 365,338,000.00 | -61,561,000.00 | 42,782,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 262,405,000.00 | -148,398,000.00 | -7,482,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -733,000.00 | 1,125,000.00 | 2,299,000.00 |
| Cash and cash equivalents | 92,065,000.00 | 353,737,000.00 | 206,464,000.00 | 201,281,000.00 |
Please note that some sums might not add up.
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 26.07.23 | Mary OConnor | Other | Buy | USD 100,792.67 |
| 19.05.23 | FERGUS MACLEOD | Other | Sell | SEK 1,672,650.00 |
| 19.05.23 | Lennart Johansson | Other | Buy | SEK 243,760.00 |
| 19.05.23 | FERGUS MACLEOD | Other | Buy | SEK 204,006.00 |
| 19.05.23 | FERGUS MACLEOD | Other | Sell | SEK 203,933.40 |
| 12.05.23 | Annelie Aava Vikner | Other | Sell | SEK 701,220.00 |
| 02.05.23 | Mary OConnor | Other | Buy | USD 58,507.09 |
| 28.04.23 | Emil Billbäck | Other | Sell | SEK 14,617,520.00 |
| 14.03.23 | Kristina Ingvar | Other | Sell | SEK 1,637,634.50 |
| 14.03.23 | Michael Diefenbeck | Other | Sell | SEK 1,364,655.90 |
SE0009858152
LEI549300COLY053IGTLD63
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.